ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Nasal Polyps
Allergic Rhinitis
Rhinitis
Rhinosinusitis
Sinusitis
Conjunctivitis

Asthma trials near Barcelona, CT, ESP:

Locations recently updated

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. (ARRIVAL)

administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...

Enrolling
Severe Asthma
Combination Product: Budesonide/formoterol
Combination Product: Mannitol

Phase 3

AstraZeneca
AstraZeneca

Barcelona, Spain and 83 other locations

Locations recently updated

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Barcelona, Spain and 83 other locations

compared with placebo in participants with moderate-to-severe asthma.Study details include:* The study duration for each participant will be...

Enrolling
Asthma
Drug: AZD4604
Drug: Placebo to AZD4604

Phase 2

AstraZeneca
AstraZeneca

Barcelona, Spain and 24 other locations

is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...

Enrolling
Asthma
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Barcelona, Spain and 102 other locations

12 years old with moderate to severe asthma....

Enrolling
Asthma
Drug: Glycopyrronium bromide 25ug
Drug: Glycopyrronium bromide 12.5ug

Phase 2

Novartis
Novartis

Barcelona, Catalunya, Spain and 21 other locations

study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...

Enrolling
Asthma
Other: Spirometry
Drug: Mepolizumab

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Barcelona, Spain and 65 other locations

Primary Objective:* To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a p...

Active, not recruiting
Asthma
Drug: Asthma reliever therapies
Drug: Asthma controller therapies (incl. prednisone/prednisolone)

Phase 3

Sanofi
Sanofi

Barcelona, Barcelona [Barcelona], Spain and 79 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Barcelona, Spain and 120 other locations

to budesonide in children from 6 to less than 12 years of age with asthma.* The study duration will be up to 37 weeks including an investiga...

Enrolling
Asthma
Drug: QMF149
Drug: Budesonide

Phase 3

Novartis
Novartis

Barcelona, Catalunya, Spain and 51 other locations

Locations recently updated

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Enrolling
Moderate to Severe Asthma
Drug: ICS-LABA
Other: placebo

Phase 2

Incyte
Incyte

Barcelona, Spain and 84 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems